Search IPOs
TBA · NSE,BSE · Pharmaceuticals
Rodec Pharma IPO is scheduled to open soon . The Mainboard IPO has a price band of TBA , with a minimum lot size of TBA . .
Rodec Pharma IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | TBA |
| IPO Close Date | TBA |
| Basis of Allotment | TBA |
| Initiation of Refunds | TBA |
| Credit of Shares to Demat | TBA |
| Listing Date | TBA |
Issue Size
[.]
Issue Price
[.]
Face Value
[.]
Market Lot
[.]
Retail Min Investment
[.]
Listing At
NSE,BSE
Sale Type
[.]
Fresh Issue
[.]
Offer for Sale
[.]
Issue Type
[.]
Open Date
TBA
Close Date
TBA
Allotment
TBA
Listing
TBA
No snapshot available yet.
Mukesh Kumar Gupta, Chhaya Gupta and Utkarsh Gupta are the promoters of the Company.
Healthy animals mean healthy livelihoods. Rodec Pharma Limited has understood this truth since the day it was founded and built an entire business around it.
Incorporated in 1997 and headquartered in Uttar Pradesh, Rodec Pharma has spent over 28 years serving the veterinary healthcare needs of India's farming community. What started as a focused pharmaceutical operation has grown into a well-respected name among veterinarians, consignee agents, and livestock farmers across the country.
The company manufactures and markets a diverse portfolio of 35 veterinary pharmaceutical drugs and animal feed supplements spanning antibiotics, analgesics, antipyretics, and anthelmintics across 29 product variants. This range makes Rodec a single-window solution for animal healthcare and nutrition, reducing the need for farmers to look elsewhere.
The financial track record speaks for itself. In FY25, revenue grew 20.73% to ₹108.19 crore, crossing the significant ₹100 crore milestone. More impressively, profit after tax jumped 65.45% to ₹18.25 crore a clear sign that the business is not just growing, but becoming more efficient with every passing year.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 71.72 | 89.61 | 108.91 |
| Profit After Tax (PAT) | 5.21 | 11.04 | 18.26 |
| EBITDA | 8.12 | 15.73 | 25.76 |
| Total Assets | 44.13 | 50.62 | 71.99 |
| Net Worth | - | - | - |
| Reserves & Surplus | 20.57 | 31.6 | 49.86 |
| Total Borrowing | - | - | - |
Revenue & Profit Trend
The allotment date for Rodec Pharma IPO will be announced after the subscription closes. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The Rodec Pharma IPO dates are coming soon. The subscription dates will be announced officially by the company and updated here once finalized.
The price band for Rodec Pharma IPO is yet to be announced.
As per market sources, Rodec Pharma IPO GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Rodec Pharma IPO is being updated. Check the latest subscription figures by category (Retail, QIB, NII) for real-time updates.
The listing date for Rodec Pharma IPO is yet to be announced and will be updated once finalized.
No comments yet. Be the first to comment!
